Reports

Industry Research Reports

description

Part 1

description

Part 2

description

Part 3

description

Part 5

Global and United States Bumetanide Market Report & Forecast 2022-2028

Global and United States Bumetanide Market Report & Forecast 2022-2028

Industry: Pharma & Healthcare

Published: 2022-06-01

Pages: 109 Pages

Report ld: 361357

  • Description 选中
  • Table of Contents 选中
  • Table of Figures 选中
  • PDF PDF Download 选中
  • Description 选中
  • Table of Contents 选中
  • Table of Figures 选中
  • PDF PDF Download 选中
Market Analysis and Insights: Global and United States Bumetanide Market
This report focuses on global and United States Bumetanide market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Bumetanide market size is estimated to be worth US$  million in 2022 and is forecast to a readjusted size of US$  million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Oral Drugs accounting for % of the Bumetanide global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Hospital was the leading segment, accounting for over  percent market share in 2021, and altered to an  % CAGR throughout this forecast period.

In United States the Bumetanide market size is expected to grow from US$  million in 2021 to US$  million by 2028, at a CAGR of % during the forecast period  2022-2028.

Global Bumetanide Scope and Market Size
Bumetanide market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Bumetanide market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Bumetanide market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type
    Oral Drugs
    Injection Drugs

Segment by Application
    Hospital
    Drug Store

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        China Taiwan
        Indonesia
        Thailand
        Malaysia
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

By Company
    Pfizer
    Teva
    Zydus Pharmaceuticals
    Validus Pharmaceuticals
    Upsher-Smith
    Guilin Nanyao Company
    Eisai
    Liaoning Yuhuang Pharmaceutical
    Amneal
    Sandoz
 1 Study Coverage
1.1 Bumetanide Product Introduction
1.2 Global Bumetanide Outlook 2017 VS 2022 VS 2028
1.2.1 Global Bumetanide Sales in US$ Million for the Year 2017-2028
1.2.2 Global Bumetanide Sales in Volume for the Year 2017-2028
1.3 United States Bumetanide Outlook 2017 VS 2022 VS 2028
1.3.1 United States Bumetanide Sales in US$ Million for the Year 2017-2028
1.3.2 United States Bumetanide Sales in Volume for the Year 2017-2028
1.4 Bumetanide Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Bumetanide in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Bumetanide Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Bumetanide Market Dynamics
1.5.1 Bumetanide Industry Trends
1.5.2 Bumetanide Market Drivers
1.5.3 Bumetanide Market Challenges
1.5.4 Bumetanide Market Restraints
1.6 Study Objectives
1.7 Years Considered

 2 Market by Type
2.1 Bumetanide Market Segment by Type
2.1.1 Oral Drugs
2.1.2 Injection Drugs
2.2 Global Bumetanide Market Size by Type
2.2.1 Global Bumetanide Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Bumetanide Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Bumetanide Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Bumetanide Market Size by Type
2.3.1 United States Bumetanide Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Bumetanide Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Bumetanide Average Selling Price (ASP) by Type (2017, 2022 & 2028)

 3 Market by Application
3.1 Bumetanide Market Segment by Application
3.1.1 Hospital
3.1.2 Drug Store
3.2 Global Bumetanide Market Size by Application
3.2.1 Global Bumetanide Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Bumetanide Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Bumetanide Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Bumetanide Market Size by Application
3.3.1 United States Bumetanide Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Bumetanide Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Bumetanide Average Selling Price (ASP) by Application (2017, 2022 & 2028)

 4 Global Bumetanide Competitor Landscape by Company
4.1 Global Bumetanide Market Size by Company
4.1.1 Top Global Bumetanide Manufacturers Ranked by Revenue (2021)
4.1.2 Global Bumetanide Revenue by Manufacturer (2017-2022)
4.1.3 Global Bumetanide Sales by Manufacturer (2017-2022)
4.1.4 Global Bumetanide Price by Manufacturer (2017-2022)
4.2 Global Bumetanide Concentration Ratio (CR)
4.2.1 Bumetanide Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Bumetanide in 2021
4.2.3 Global Bumetanide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Bumetanide Manufacturing Base Distribution, Product Type
4.3.1 Global Bumetanide Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Bumetanide Product Type
4.3.3 Date of International Manufacturers Enter into Bumetanide Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Bumetanide Market Size by Company
4.5.1 Top Bumetanide Players in United States, Ranked by Revenue (2021)
4.5.2 United States Bumetanide Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Bumetanide Sales by Players (2020, 2021 & 2022)

 5 Global Bumetanide Market Size by Region
5.1 Global Bumetanide Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Bumetanide Market Size in Volume by Region (2017-2028)
5.2.1 Global Bumetanide Sales in Volume by Region: 2017-2022
5.2.2 Global Bumetanide Sales in Volume Forecast by Region (2023-2028)
5.3 Global Bumetanide Market Size in Value by Region (2017-2028)
5.3.1 Global Bumetanide Sales in Value by Region: 2017-2022
5.3.2 Global Bumetanide Sales in Value by Region: 2023-2028

 6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Bumetanide Market Size YoY Growth 2017-2028
6.1.2 North America Bumetanide Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 United States
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Bumetanide Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Bumetanide Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 China Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.3 Europe
6.3.1 Europe Bumetanide Market Size YoY Growth 2017-2028
6.3.2 Europe Bumetanide Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Bumetanide Market Size YoY Growth 2017-2028
6.4.2 Latin America Bumetanide Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Bumetanide Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Bumetanide Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE

 7 Company Profiles
7.1 Pfizer
7.1.1 Pfizer Corporation Information
7.1.2 Pfizer Description and Business Overview
7.1.3 Pfizer Bumetanide Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Pfizer Bumetanide Products Offered
7.1.5 Pfizer Recent Development
7.2 Teva
7.2.1 Teva Corporation Information
7.2.2 Teva Description and Business Overview
7.2.3 Teva Bumetanide Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Teva Bumetanide Products Offered
7.2.5 Teva Recent Development
7.3 Zydus Pharmaceuticals
7.3.1 Zydus Pharmaceuticals Corporation Information
7.3.2 Zydus Pharmaceuticals Description and Business Overview
7.3.3 Zydus Pharmaceuticals Bumetanide Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Zydus Pharmaceuticals Bumetanide Products Offered
7.3.5 Zydus Pharmaceuticals Recent Development
7.4 Validus Pharmaceuticals
7.4.1 Validus Pharmaceuticals Corporation Information
7.4.2 Validus Pharmaceuticals Description and Business Overview
7.4.3 Validus Pharmaceuticals Bumetanide Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Validus Pharmaceuticals Bumetanide Products Offered
7.4.5 Validus Pharmaceuticals Recent Development
7.5 Upsher-Smith
7.5.1 Upsher-Smith Corporation Information
7.5.2 Upsher-Smith Description and Business Overview
7.5.3 Upsher-Smith Bumetanide Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Upsher-Smith Bumetanide Products Offered
7.5.5 Upsher-Smith Recent Development
7.6 Guilin Nanyao Company
7.6.1 Guilin Nanyao Company Corporation Information
7.6.2 Guilin Nanyao Company Description and Business Overview
7.6.3 Guilin Nanyao Company Bumetanide Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Guilin Nanyao Company Bumetanide Products Offered
7.6.5 Guilin Nanyao Company Recent Development
7.7 Eisai
7.7.1 Eisai Corporation Information
7.7.2 Eisai Description and Business Overview
7.7.3 Eisai Bumetanide Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Eisai Bumetanide Products Offered
7.7.5 Eisai Recent Development
7.8 Liaoning Yuhuang Pharmaceutical
7.8.1 Liaoning Yuhuang Pharmaceutical Corporation Information
7.8.2 Liaoning Yuhuang Pharmaceutical Description and Business Overview
7.8.3 Liaoning Yuhuang Pharmaceutical Bumetanide Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Liaoning Yuhuang Pharmaceutical Bumetanide Products Offered
7.8.5 Liaoning Yuhuang Pharmaceutical Recent Development
7.9 Amneal
7.9.1 Amneal Corporation Information
7.9.2 Amneal Description and Business Overview
7.9.3 Amneal Bumetanide Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Amneal Bumetanide Products Offered
7.9.5 Amneal Recent Development
7.10 Sandoz
7.10.1 Sandoz Corporation Information
7.10.2 Sandoz Description and Business Overview
7.10.3 Sandoz Bumetanide Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Sandoz Bumetanide Products Offered
7.10.5 Sandoz Recent Development

 8 Industry Chain and Sales Channels Analysis
8.1 Bumetanide Industry Chain Analysis
8.2 Bumetanide Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Bumetanide Distributors
8.3 Bumetanide Production Mode & Process
8.4 Bumetanide Sales and Marketing
8.4.1 Bumetanide Sales Channels
8.4.2 Bumetanide Distributors
8.5 Bumetanide Customers

 9 Research Findings and Conclusion

 10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Bumetanide CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Bumetanide Market Trends
    Table 3. Bumetanide Market Drivers
    Table 4. Bumetanide Market Challenges
    Table 5. Bumetanide Market Restraints
    Table 6. Global Bumetanide Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Bumetanide Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Bumetanide Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Bumetanide Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Bumetanide Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Bumetanide Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Bumetanide Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Bumetanide Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Bumetanide Sales Share by Manufacturer, 2017-2022
    Table 15. Global Bumetanide Price by Manufacturer (2017-2022) & (US$/Unit)
    Table 16. Global Bumetanide Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Bumetanide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bumetanide as of 2021)
    Table 18. Top Players of Bumetanide in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Bumetanide Product Type
    Table 20. Date of International Manufacturers Enter into Bumetanide Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Bumetanide Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Bumetanide Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Bumetanide Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Bumetanide Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Bumetanide Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Bumetanide Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Bumetanide Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Bumetanide Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Bumetanide Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Bumetanide Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Bumetanide Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Bumetanide Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Bumetanide Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Bumetanide Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Bumetanide Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Bumetanide Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Bumetanide Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Bumetanide Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Bumetanide Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Bumetanide Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Pfizer Corporation Information
    Table 43. Pfizer Description and Business Overview
    Table 44. Pfizer Bumetanide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 45. Pfizer Bumetanide Product
    Table 46. Pfizer Recent Development
    Table 47. Teva Corporation Information
    Table 48. Teva Description and Business Overview
    Table 49. Teva Bumetanide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 50. Teva Product
    Table 51. Teva Recent Development
    Table 52. Zydus Pharmaceuticals Corporation Information
    Table 53. Zydus Pharmaceuticals Description and Business Overview
    Table 54. Zydus Pharmaceuticals Bumetanide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 55. Zydus Pharmaceuticals Product
    Table 56. Zydus Pharmaceuticals Recent Development
    Table 57. Validus Pharmaceuticals Corporation Information
    Table 58. Validus Pharmaceuticals Description and Business Overview
    Table 59. Validus Pharmaceuticals Bumetanide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 60. Validus Pharmaceuticals Product
    Table 61. Validus Pharmaceuticals Recent Development
    Table 62. Upsher-Smith Corporation Information
    Table 63. Upsher-Smith Description and Business Overview
    Table 64. Upsher-Smith Bumetanide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 65. Upsher-Smith Product
    Table 66. Upsher-Smith Recent Development
    Table 67. Guilin Nanyao Company Corporation Information
    Table 68. Guilin Nanyao Company Description and Business Overview
    Table 69. Guilin Nanyao Company Bumetanide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 70. Guilin Nanyao Company Product
    Table 71. Guilin Nanyao Company Recent Development
    Table 72. Eisai Corporation Information
    Table 73. Eisai Description and Business Overview
    Table 74. Eisai Bumetanide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 75. Eisai Product
    Table 76. Eisai Recent Development
    Table 77. Liaoning Yuhuang Pharmaceutical Corporation Information
    Table 78. Liaoning Yuhuang Pharmaceutical Description and Business Overview
    Table 79. Liaoning Yuhuang Pharmaceutical Bumetanide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 80. Liaoning Yuhuang Pharmaceutical Product
    Table 81. Liaoning Yuhuang Pharmaceutical Recent Development
    Table 82. Amneal Corporation Information
    Table 83. Amneal Description and Business Overview
    Table 84. Amneal Bumetanide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 85. Amneal Product
    Table 86. Amneal Recent Development
    Table 87. Sandoz Corporation Information
    Table 88. Sandoz Description and Business Overview
    Table 89. Sandoz Bumetanide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 90. Sandoz Product
    Table 91. Sandoz Recent Development
    Table 92. Key Raw Materials Lists
    Table 93. Raw Materials Key Suppliers Lists
    Table 94. Bumetanide Customers List
    Table 95. Bumetanide Distributors List
    Table 96. Research Programs/Design for This Report
    Table 97. Key Data Information from Secondary Sources
    Table 98. Key Data Information from Primary Sources
List of Figures
    Figure 1. Bumetanide Product Picture
    Figure 2. Global Bumetanide Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Bumetanide Market Size 2017-2028 (US$ Million)
    Figure 4. Global Bumetanide Sales 2017-2028 (K Units)
    Figure 5. United States Bumetanide Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Bumetanide Market Size 2017-2028 (US$ Million)
    Figure 7. United States Bumetanide Sales 2017-2028 (K Units)
    Figure 8. United States Bumetanide Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Bumetanide Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Bumetanide Report Years Considered
    Figure 11. Product Picture of Oral Drugs
    Figure 12. Product Picture of Injection Drugs
    Figure 13. Global Bumetanide Market Share by Type in 2022 & 2028
    Figure 14. Global Bumetanide Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 15. Global Bumetanide Sales Market Share in Value by Type (2017-2028)
    Figure 16. Global Bumetanide Sales by Type (2017-2028) & (K Units)
    Figure 17. Global Bumetanide Sales Market Share in Volume by Type (2017-2028)
    Figure 18. Global Bumetanide Price by Type (2017-2028) & (US$/Unit)
    Figure 19. United States Bumetanide Market Share by Type in 2022 & 2028
    Figure 20. United States Bumetanide Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 21. United States Bumetanide Sales Market Share in Value by Type (2017-2028)
    Figure 22. United States Bumetanide Sales by Type (2017-2028) & (K Units)
    Figure 23. United States Bumetanide Sales Market Share in Volume by Type (2017-2028)
    Figure 24. United States Bumetanide Price by Type (2017-2028) & (US$/Unit)
    Figure 25. Product Picture of Hospital
    Figure 26. Product Picture of Drug Store
    Figure 27. Global Bumetanide Market Share by Application in 2022 & 2028
    Figure 28. Global Bumetanide Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 29. Global Bumetanide Sales Market Share in Value by Application (2017-2028)
    Figure 30. Global Bumetanide Sales by Application (2017-2028) & (K Units)
    Figure 31. Global Bumetanide Sales Market Share in Volume by Application (2017-2028)
    Figure 32. Global Bumetanide Price by Application (2017-2028) & (US$/Unit)
    Figure 33. United States Bumetanide Market Share by Application in 2022 & 2028
    Figure 34. United States Bumetanide Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 35. United States Bumetanide Sales Market Share in Value by Application (2017-2028)
    Figure 36. United States Bumetanide Sales by Application (2017-2028) & (K Units)
    Figure 37. United States Bumetanide Sales Market Share in Volume by Application (2017-2028)
    Figure 38. United States Bumetanide Price by Application (2017-2028) & (US$/Unit)
    Figure 39. North America Bumetanide Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 40. North America Bumetanide Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 41. United States Bumetanide Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Canada Bumetanide Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Europe Bumetanide Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 44. Europe Bumetanide Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 45. Germany Bumetanide Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 46. France Bumetanide Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. U.K. Bumetanide Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Italy Bumetanide Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Russia Bumetanide Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Asia-Pacific Bumetanide Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 51. Asia-Pacific Bumetanide Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 52. China Bumetanide Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Japan Bumetanide Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. South Korea Bumetanide Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. India Bumetanide Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Australia Bumetanide Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. China Taiwan Bumetanide Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Indonesia Bumetanide Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Thailand Bumetanide Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Malaysia Bumetanide Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Latin America Bumetanide Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 62. Latin America Bumetanide Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 63. Mexico Bumetanide Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Brazil Bumetanide Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Argentina Bumetanide Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Middle East & Africa Bumetanide Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 67. Middle East & Africa Bumetanide Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 68. Turkey Bumetanide Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Saudi Arabia Bumetanide Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. UAE Bumetanide Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Bumetanide Value Chain
    Figure 72. Bumetanide Production Process
    Figure 73. Channels of Distribution
    Figure 74. Distributors Profiles
    Figure 75. Bottom-up and Top-down Approaches for This Report
    Figure 76. Data Triangulation
    Figure 77. Key Executives Interviewed
Market Analysis and Insights: Global and United States Bumetanide Market
This report focuses on global and United States Bumetanide market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Bumetanide market size is estimated to be worth US$  million in 2022 and is forecast to a readjusted size of US$  million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Oral Drugs accounting for % of the Bumetanide global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Hospital was the leading segment, accounting for over  percent market share in 2021, and altered to an  % CAGR throughout this forecast period.

In United States the Bumetanide market size is expected to grow from US$  million in 2021 to US$  million by 2028, at a CAGR of % during the forecast period  2022-2028.

Global Bumetanide Scope and Market Size
Bumetanide market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Bumetanide market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Bumetanide market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type
    Oral Drugs
    Injection Drugs

Segment by Application
    Hospital
    Drug Store

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        China Taiwan
        Indonesia
        Thailand
        Malaysia
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

By Company
    Pfizer
    Teva
    Zydus Pharmaceuticals
    Validus Pharmaceuticals
    Upsher-Smith
    Guilin Nanyao Company
    Eisai
    Liaoning Yuhuang Pharmaceutical
    Amneal
    Sandoz
    
Global and United States Bumetanide Market Report & Forecast 2022-2028

Industry: Pharma & Healthcare

Published: 2022-06-01

Pages: 109 Pages

Report ld: 361357

CHOOSE LICENSE TYPE
提示

USD 4350.00

提示

USD 6525.00

提示

USD 8700.00

/uploads/payment/payIcon/masterCard-01.svg/uploads/payment/payIcon/american-express-01.svg/uploads/payment/payIcon/visa-01.svg/uploads/payment/payIcon/diners-club-01.svg/uploads/payment/payIcon/discover-4-01.svg/uploads/payment/payIcon/jcb-01.svg
加入购物车

Add to Cart

立即购买

Buy Now

A comprehensive and in-depth analysis of current industry data on markets, competitors and suppliers.

In-depth research on key industry players and analysis of production and sales operations.

Objective forecasts of future trends in the industry.

WHAT QYRESEARCH OFFER?
Competition

Competition

Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.

Industry Analysis

Industry Analysis

Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.

Market Size

Market Size

Capacity, production, sales, revenue, price, cost etc.

Customized Information

Customized Information

We can offer customized survey and information to meet ourclient's need.

INTEREST IN THIS REPORT?

Get A Free Sample >>
WHY QYR?
  • Fastest report delivery service

    Fastest report delivery service

  • More than 17 years of vast experience

    More than 17 years of vast experience

  • Operation for 24 * 7 & 365 days

    Operation for 24 * 7 & 365 days

  • In-depth and comprehensive analysis

    In-depth and comprehensive analysis

  • Professional and timely after-sales service

    Professional and timely after-sales service

  • Owns large database

    Owns large database

A comprehensive and in-depth analysis of current industry data on markets, competitors and suppliers.

In-depth research on key industry players and analysis of production and sales operations.

Objective forecasts of future trends in the industry.

WHAT QYRESEARCH OFFER?
Competition

Competition

Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.

Industry Analysis

Industry Analysis

Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.

Market Size

Market Size

Capacity, production, sales, revenue, price, cost etc.

Customized Information

Customized Information

We can offer customized survey and information to meet ourclient's need.

INTEREST IN THIS REPORT?

Get A Free Sample >>
WHY QYR?
  • Fastest report delivery service

    Fastest report delivery service

  • More than 17 years of vast experience

    More than 17 years of vast experience

  • Operation for 24 * 7 & 365 days

    Operation for 24 * 7 & 365 days

  • In-depth and comprehensive analysis

    In-depth and comprehensive analysis

  • Professional and timely after-sales service

    Professional and timely after-sales service

  • Owns large database

    Owns large database

biaoTi

WORLD WIDE OFFICE

加入购物车

Add to Cart

立即购买

Buy Now